List of Field Safety Notices from 19 to 23 May 2025.
Similar Posts
FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan)
Listen to an audio podcast of the November 28, 2023, FDA Drug Safety Communication, FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan).

Building a Loyal Blog Audience: Strategies for Engagement and Growth
Introduction Growing a dedicated and engaged audience is a critical aspect of successful blogging. This post explores effective strategies to build and maintain a loyal readership for your blog. 1. Know Your Audience Understanding who your readers are is fundamental. Tailor your content to their interests, needs, and preferences. Use analytics tools to gain insights…
FDA Drug Safety Podcasts
FDA Drug Safety Podcasts are produced by FDA’s Center for Drug Evaluation and Research (CDER)
Infusion Pump Recall: False Alarm Issue with Infusion Pump from Smiths Medical
False Alarm Issue with Infusion Pump from Smiths Medical

Crafting the Perfect Blog Structure: A Guide for Effective Blogging
Introduction Every great blog post starts with a solid structure. A well-structured blog not only enhances readability but also keeps your readers engaged. This post will explore the key elements of an effective blog structure. 1. Captivating Headline Your headline is the first thing readers see. Make it catchy, clear, and concise. It should pique…
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis